# Enveric Biosciences, Inc.: Form 8-K, filed Jan 4, 2017

- Company: [Enveric Biosciences, Inc.](/companies/envb.md) (CIK 890821)
- Form: 8-K
- Filed: 2017-01-04
- Accepted by EDGAR: Jan 4, 2017, 16:10 ET
- Period: 2016-12-30
- Accession: 0000921895-17-000021
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/890821/000092189517000021/form8k10211002_01042017.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/890821/000092189517000021/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/890821/000092189517000021/form8k10211002_01042017.htm

Filed Jan 4, 2017.
Source: SEC EDGAR, the filing index for accession 0000921895-17-000021. Last ingested by Listed: Nov 14, 2026, 20:02 ET. No prices; not investment advice.
